Literature DB >> 12620638

Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages.

Nilka Tomassini1, Fernando L Renaud, Sabita Roy, Horace H Loh.   

Abstract

Studies with selective opioid agonists show that mu- and delta(2)-opioid receptors, but not kappa, are involved in opioid inhibition of phagocytosis in elicited murine macrophages. All mu and delta(2) agonists tested had similar maximal effects on phagocytosis, and all dose-response curves suggest positive cooperativity. In addition, mu and delta antagonists antagonized the effect of both mu and delta agonists. Furthermore, in mu-opioid receptor knockout mice (MORKO), we observed a decrease in potency and maximal effect for a delta agonist. These data suggest that mu and delta receptors are not only involved in the modulation of phagocytosis in macrophages, but they also affect each other's activity by an unknown cooperative mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620638     DOI: 10.1016/s0165-5728(02)00463-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

2.  Opioids and the immune system: what is their mechanism of action?

Authors:  Toby K Eisenstein
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 3.  Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

Authors:  B Afsharimani; C W Doornebal; P J Cabot; M W Hollmann; M-O Parat
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

5.  The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice.

Authors:  Olga Pol; Masayuki Sasaki; Natàlia Jiménez; Valina L Dawson; Ted M Dawson; Margarita M Puig
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 6.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

7.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

8.  Morphine reduces mouse microglial engulfment induced by lipopolysaccharide and interferon-γ via δ opioid receptor and p38 mitogen-activated protein kinase.

Authors:  Jung-Hee Ryu; Sang-Hwan Do; Sung-Hee Han; Zhiyi Zuo
Journal:  Neurol Res       Date:  2018-03-27       Impact factor: 2.448

Review 9.  RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.

Authors:  Maciej Salaga; Martin Storr; Kirill A Martemyanov; Jakub Fichna
Journal:  Bioessays       Date:  2016-01-28       Impact factor: 4.345

Review 10.  Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.

Authors:  Marta Sobczak; Maciej Sałaga; Martin A Storr; Jakub Fichna
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.